• ABL Diagnostics announced board member Advanced Biological Laboratories sold 60,000 shares at EUR 2.5 each in an off-market transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.